Starpharma Holdings Ltd - Asset Resilience Ratio

Latest as of December 2025: 69.74%

Starpharma Holdings Ltd (SPL) has an Asset Resilience Ratio of 69.74% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SPL working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$18.25 Million

≈ $12.91 Million USD Cash + Short-term Investments

Total Assets

AU$26.17 Million

≈ $18.51 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Starpharma Holdings Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Starpharma Holdings Ltd.

Liquid Assets Composition Over Time

This chart breaks down Starpharma Holdings Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read debt load of Starpharma Holdings Ltd for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$18.25 Million	69.74%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$18.25 Million	69.74%

Asset Resilience Insights

Very High Liquidity: Starpharma Holdings Ltd maintains exceptional liquid asset reserves at 69.74% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Starpharma Holdings Ltd Industry Peers by Asset Resilience Ratio

Compare Starpharma Holdings Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Abivax SA PA:ABVX	Biotechnology	2.58%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Lifecome Biochemistry Co Ltd SHE:002868	Biotechnology	4.69%
Pulike Biological Engineering SHG:603566	Biotechnology	17.82%
Rocket Pharmaceuticals Inc NASDAQ:RCKT	Biotechnology	14.00%
NEWRON PHARMACEUT. EO-20 XETRA:NP5	Biotechnology	41.67%
Upstream Bio, Inc. NASDAQ:UPB	Biotechnology	64.70%

Annual Asset Resilience Ratio for Starpharma Holdings Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Starpharma Holdings Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	59.40%	AU$15.10 Million ≈ $10.68 Million	AU$25.42 Million ≈ $17.99 Million	-2.61pp
2024-06-30	62.01%	AU$22.83 Million ≈ $16.15 Million	AU$36.81 Million ≈ $26.05 Million	-2.34pp
2023-06-30	64.35%	AU$33.52 Million ≈ $23.72 Million	AU$52.09 Million ≈ $36.85 Million	-4.85pp
2022-06-30	69.20%	AU$45.79 Million ≈ $32.40 Million	AU$66.17 Million ≈ $46.82 Million	-9.04pp
2021-06-30	78.24%	AU$57.30 Million ≈ $40.54 Million	AU$73.24 Million ≈ $51.82 Million	+11.74pp
2020-06-30	66.49%	AU$25.98 Million ≈ $18.39 Million	AU$39.08 Million ≈ $27.65 Million	-11.91pp
2019-06-30	78.40%	AU$38.31 Million ≈ $27.10 Million	AU$48.86 Million ≈ $34.57 Million	-3.58pp
2018-06-30	81.98%	AU$47.97 Million ≈ $33.94 Million	AU$58.51 Million ≈ $41.40 Million	-4.88pp
2017-06-30	86.85%	AU$57.84 Million ≈ $40.92 Million	AU$66.59 Million ≈ $47.12 Million	--
2016-06-30	0.00%	AU$0.00 ≈ $0.00	AU$59.04 Million ≈ $41.77 Million	--

pp = percentage points

About Starpharma Holdings Ltd

AU:SPL Australia Biotechnology

Market Cap

$273.41 Million

AU$386.41 Million AUD

Market Cap Rank

#15400 Global

#411 in Australia

Share Price

AU$0.81

Change (1 day)

+1.89%

52-Week Range

AU$0.22 - AU$0.81

All Time High

AU$2.49